Abstract
Hapten-immune mice are capable of rejecting syngeneic skin grafts that are derivatized with the relevant hapten, but only if the hapten is applied while the graft is "healing in." This model system was used to demonstrate that the hapten-specific immune effectors responsible for rejection are restricted by H-2 determinants of the recipient. Thus, haptens can be used in vivo as surrogate transplantation antigens for the study of immunopathogenic mechanisms in transplantation immunity.
Full Text
The Full Text of this article is available as a PDF (496.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ascher N. L., Chen S., Hoffman R., Simmons R. L. Maturation of cytotoxic effector cells at the site of allograft rejection. Transplant Proc. 1981 Mar;13(1 Pt 2):1105–1107. [PubMed] [Google Scholar]
- Billingham R. E. The feasibility of altering the immunogenicity of grafts. J Invest Dermatol. 1976 Jul;67(1):149–159. doi: 10.1111/1523-1747.ep12513006. [DOI] [PubMed] [Google Scholar]
- Forman J., Streilein J. W. T cells recognize minor histocompatibility antigens on H-2 allogeneic cells. J Exp Med. 1979 Oct 1;150(4):1001–1007. doi: 10.1084/jem.150.4.1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huber B., Devinsky O., Gershon R. K., Cantor H. Cell-mediated immunity: delayed-type hypersensitivity and cytotoxic responses are mediated by different T-cell subclasses. J Exp Med. 1976 Jun 1;143(6):1534–1539. doi: 10.1084/jem.143.6.1534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jooste S. V., Colvin R. B., Soper W. D., Winn H. J. The vascular bed as the primary target in the destruction of skin grafts by antiserum. I. Resistance of freshly placed xenografts of skin to antiserum. J Exp Med. 1981 Nov 1;154(5):1319–1331. doi: 10.1084/jem.154.5.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jooste S. V., Colvin R. B., Winn H. J. The vascular bed as the primary target in the destruction of skin grafts by antiserum. II. Loss of sensitivity to antiserum in long-term xenografts of skin. J Exp Med. 1981 Nov 1;154(5):1332–1341. doi: 10.1084/jem.154.5.1332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Korngold R., Sprent J. H-2 restriction of T cells causing lethal graft-versus-host disease across minor histocompatibility barriers in mice. Transplant Proc. 1981 Mar;13(1 Pt 2):1217–1219. [PubMed] [Google Scholar]
- Loveland B. E., Hogarth P. M., Ceredig R., McKenzie I. F. Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med. 1981 May 1;153(5):1044–1057. doi: 10.1084/jem.153.5.1044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Silvers W. K., Fleming H. L., Naji A., Barker C. F. Evidence for major histocompatibility complex restriction in transplantation immunity. Proc Natl Acad Sci U S A. 1982 Jan;79(1):171–174. doi: 10.1073/pnas.79.1.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Streilein J. W., Gruchalla R. S., Wood P., Strome P. Active clonal deletion in neonatal H-2 tolerance. Ann N Y Acad Sci. 1982;392:276–290. doi: 10.1111/j.1749-6632.1982.tb36113.x. [DOI] [PubMed] [Google Scholar]
- Streilein J. W., Klein J. Neonatal tolerance induction across regions of H-2 complex. J Immunol. 1977 Dec;119(6):2147–2150. [PubMed] [Google Scholar]
- Sunday M. E., Dorf M. E. Hapten-specific T cell response to 4-hydroxy-3-nitrophenyl acetyl. X. Characterization of distinct T cell subsets mediating cutaneous sensitivity responses. J Immunol. 1981 Aug;127(2):766–768. [PubMed] [Google Scholar]
- Tagart V. Cytotoxicity in picryl chloride-painted mice is enhanced by pretreatment with cyclophosphamide. Transplantation. 1977 Mar;23(3):287–289. [PubMed] [Google Scholar]
- Toews G. B., Bergstresser P. R., Streilein J. W. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol. 1980 Jan;124(1):445–453. [PubMed] [Google Scholar]